Beam Therapeutics CEO John Evans sells $1.19m in company stock

Blue Owl Founders Promised a Comeback. The Company’s Share Price Hasn’t Budged.

Dow Jones · Markets 27m ago

Goldcana plans C$1 million flow-through private placement

Investing.com · News 38m ago

Adaptive biotechnologies president & COO Rubinstein sells $897k stock

Investing.com · News 40m ago

Zone Frontier CEO Tyler Hassen buys $55,150 in common stock

Investing.com · News 41m ago

Iran war: Missiles target Saudi oil hub as Yemen conflict escalates

Investing.com · News 47m ago

Blaize declares preferred stock dividend ahead of potential reverse split

Investing.com · News 50m ago

Kratos Defense’s president Carrai disposes of $259,116 in common stock

Investing.com · News 55m ago

BillionToOne CEO Oguzhan Atay sells $1.09 million in stock

Investing.com · News 55m ago

StandardAero’s chief legal officer sells $16,567 in company stock

Investing.com · News 56m ago

Prediction: Alphabet Will Be a Larger Company Than Apple by the End of 2027

NASDAQ · Markets 58m ago